Benzinga | Jan 24, 2022 12:44PM EST

'FDA expected to sharply restrict use of two monoclonal antibodies, spurring a halt in federal shipments of the covid-19 treatments' -The Washington Post Report

https://www.washingtonpost.com/health/2022/01/24/biden-administration-monoclonal-antibodies/